Dyadic Announces Analyst Coverage Initiated by Zacks Small-Cap Research
JUPITER, Fla., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development and lower …